We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
GlaxoSmithKline previously announced it would delay a phase 2b trial of its adjuvanted vaccine candidate developed with Sanofi following lackluster results. Read More
The handheld device directs precise wavelengths of targeted light to the back of the throat and surrounding tissues and is designed for at-home treatment of mild-to-moderate COVID-19 in adult patients. Read More
Aktiia said that the monitoring system, which tracks patients throughout the day and while they sleep, is now available for pre-ordering in the UK. Read More